Table 4.
Compound | IC50 (μM)a mean ± SD |
|
---|---|---|
L1210 | CT-26 | |
1 | 1.5 ± 0.4 | 5.7 ± 0.2 |
2 | >50 | >50 |
Satraplatin | 2.5 ± 0.2 | 2.9 ± 0.3 |
50 % inhibitory concentrations (means ± standard deviations from at least three independent experiments), as obtained by the MTT assay, 72 h exposure